Why isn't Biotronik doing better?

Quote












Anonymous said:
tough question.

my guess is that the US portion of the compnay really needs some US leadership

peace out and Merry Christmas to All ...........
Click to expand...

The question is: after everything that's been documented - why isn't Boston and STJ doing worse?

The facts are that physicians are creatures of habit. Despite reams of evidence why they should walk away from these repeat offenders - they just can't. Conversely, after years of being told lies about Biotronik, they can't seem to move past them to the truth. I was blessed to have a doc who just wanted something that worked at a fair price. No studies. No payola. Just a doc and a rep meeting 7 or 8 times a month to implant.
 






Anonymous said:
How about this one: no lead recalls in 45 years of manufacturing them? Don't take my word for it - ask Boston Scientific who they buy 'their' Dextrus leads from. Ask Sorin who they will be buying all their leads from in the near future. Regardless, even if we just went back to 2004 - there's a clear reliability leader in CRM. The problem is and always has been lack of coverage and the lack of desire to 'be the first one' to use the product.

This moment in time is Biotronik's big shot. Not because of the reliability issues, but because of price pressure. The RIFFs are a clear indication that the Big 3 see the future if pricing, and it's not enough to keep all these people in the field. Biotronik is already lean and can provide a quality product for less. 5 years from now - the window will be closed and 2000 pacer systems will be the norm, brokered by GPOs in deals struck with company 'account managers' and not sales reps.
Click to expand...

OK, fine...but seriously, why isn't Biotronik doing better? Let's avoid all the nasty bs about the products and personalities in the field and find an answer to this question.
 






Anonymous said:
This quality issue is being hyped by competitive reps. It is not an issue with physicians. I think Bio's problem is the lack of break-through technology. Actually that is a problem for all vendors, but I think it is difficult for docs to add a 4th company with "me-too" products.
Click to expand...

Price price price....we're all "me-too" now.
 






Anonymous said:
Price price price....we're all "me-too" now.
Click to expand...

Yep, right now --- and moving forward --- with society's aging demographics and a (wide)spread inability to balance the government BUDGETS around the globe, it is essential to provide more service to more patients, while capping, or reducing, total healthcare outlays.
Anyone who really thinks that the current US-healthcare delivery model can survive the onslought of 40M baby boomers (all Medicare-linked after age 65!!) is really smokin' wacky weed.
Instead of focusing on 'disruptive technologies', the future share-gainers will be capitalizing on 'disruptive business practices'. Not necessaly more technology, but rather, more efficient delivery models.
 






Anonymous said:
Okay...so this argument asks me to believe that all the undocumented quality issues on Biotronik's part somehow stack up evenly against the clearly documented issues of our competition? Okay...let's continue down that path. If all European physicians are kept silent by hush money, I guess that means there's thousands MORE undocumented Medtronic, Boston and STJ issues in the European market. I mean, why would they voluntarily keep quiet about the Big 3 and only expect us to pay for their silence?

There are so many other ways to attack us...why use illogical ones?
Click to expand...


It's quite simple; the most corrupt company with regards to paying off Drs, see Las Vegas business, really reports its problems honestly!? How naive do you want to be?
 






When the las Vegas crew was with GDT, nobody cared. They move to BIO and it's a news story. Get real, this is CRM, good sales reps move the business with them. Get over it.
 






Anonymous said:
It's quite simple; the most corrupt company with regards to paying off Drs, see Las Vegas business, really reports its problems honestly!? How naive do you want to be?
Click to expand...

Biotronik has been around for 44 years...the quality record predates Vegas by decades. So you choose to bury your head in the sand...fine.
 












Anonymous said:
It's quite simple; the most corrupt company with regards to paying off Drs, see Las Vegas business, really reports its problems honestly!? How naive do you want to be?
Click to expand...

Biotronik has been around for 44 years...the quality record predates Vegas by decades. So you choose to bury your head in the sand...fine.
 












It's not about Vegas or anything in Europe. This started out as a pretty good thread before the morons started posting. Please post elsewhere.

Why isn't Biotronik doing better?
 












Anonymous said:
It's not about Vegas or anything in Europe. This started out as a pretty good thread before the morons started posting. Please post elsewhere.

Why isn't Biotronik doing better?
Click to expand...

It's no mystery really. The first hurdle is always lack of coverage. If there is a "local rep", they have to be good enough to rise above the perception that Biotronik buys business or only hires cast-offs from the Big 3.

If all the Stars and Planets align, the absolute biggest challenge will always be getting a doc confident enough to "be the first one". Once a rep can point to another physician and say, "he/she uses me" it lowers the bar for their peers.

The recalls really have little to no effect or any of this. I am biased, but if you have a Biotronik rep who has navigated all this without resorting to the unethical - then you are looking at someone who has truly 'sold' a product from the ground up.
 






Anonymous said:
Quality..?. In Europe they have no record on quality or integrity
Click to expand...

yeah, I would have to agree, here. There is NO European requirement to document the serial numbers of implanted leads in an independent database.

Logic would then instruct you how many faulty leads see the light of day. The FDA is one of the few international organizations that REQUIRES the individual tracking of lead placement data on a per-patient level. Fact.
 






Anonymous said:
Quality..?. In Europe they have no record on quality or integrity
Click to expand...

yeah, I would have to agree, here. There is NO European requirement to document the serial numbers of implanted leads in an independent database.

Logic would then instruct you how many faulty leads see the light of day. The FDA is one of the few international organizations that REQUIRES the individual tracking of lead placement data on a per-patient level. Fact.
 






Anonymous said:
It's no mystery really. The first hurdle is always lack of coverage. If there is a "local rep", they have to be good enough to rise above the perception that Biotronik buys business or only hires cast-offs from the Big 3.

If all the Stars and Planets align, the absolute biggest challenge will always be getting a doc confident enough to "be the first one". Once a rep can point to another physician and say, "he/she uses me" it lowers the bar for their peers.

The recalls really have little to no effect or any of this. I am biased, but if you have a Biotronik rep who has navigated all this without resorting to the unethical - then you are looking at someone who has truly 'sold' a product from the ground up.
Click to expand...

Agreed, but even with a good support team in place, I think it is very difficult for customers to add any company as it entails learning new technology for patient follow-up. To break into the business a company like Bio needs to design products like Apple that are so intuitive to use that there is no added follow-up burden.
 






Anonymous said:
yeah, I would have to agree, here. There is NO European requirement to document the serial numbers of implanted leads in an independent database.

Logic would then instruct you how many faulty leads see the light of day. The FDA is one of the few international organizations that REQUIRES the individual tracking of lead placement data on a per-patient level. Fact.
Click to expand...

I really don't get you guys...forget Europe...we implant here under the same FDA requirements as you guys...even with our smaller volume, problems would arise if there were quality issues. Boston buys our leads. Sorin buys our leads. Neither of those houses need to invite more problems in - so buy Biotronik if you are looking for quality. Even if you guys conceded the quality nod to us, it probably won't change much in terms of market share, so just drop this 'Europeans don't have the same standards' - they do if they sell here. The cans are 85% done in Portland anyway...
 












Top Bottom
Back
Quote